@prefix n9j: <http://data.loterre.fr/ark:/67375/N9J> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix isothes: <http://purl.org/iso25964/skos-thes#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

n9j:-QF10Q6D4-F
  skos:prefLabel "types of cancer"@en ;
  a skos:Concept ;
  skos:narrower n9j:-NM7MFDP8-R .

n9j:-concepts
  a isothes:ConceptGroup ;
  skos:prefLabel "concepts"@en ;
  skos:member n9j:-NM7MFDP8-R .

n9j:-NM7MFDP8-R
  owl:sameAs <https://concepts.sagepub.com/social-science/concept/chronic_myelogenous_leukemia> ;
  skos:definition "CHRONIC MYELOGENOUS LEUKEMIA (CML) is a malignant clonal disorder of hematopoietic stem cells that results in increases in myeloid cells, erythroid cells, and platelets in the peripheral blood. Philadelphia (Ph) chromosome, formed via translocation t (9; 22), is the cytogenetic hallmark of CML. The translocation forms a chimeric gene, bcr-abl, that generates BCR-ABL, a fusion protein that constitutively activates ABL tyrosine kinase and causes CML. CML has an incidence of 1 to 2 cases per 100,000 people per year and accounts for 15 percent of leukemias in adults. [Source: Encyclopedia of Cancer and Society; Leukemia, Chronic Myelogenous]"@en ;
  a skos:Concept ;
  skos:inScheme n9j: ;
  skos:broader n9j:-QF10Q6D4-F ;
  skos:prefLabel "chronic myelogenous leukemia"@en .

n9j: a skos:ConceptScheme .